The Galveston National Laboratory
As one of two National Biocontainment Laboratories to be constructed under
grants awarded by the National Institute of Allergy and Infectious
Diseases/National Institutes of Health (NIAID/NIH), the Galveston National
Laboratory (GNL) will provide
much-needed research space to develop therapies, vaccines and diagnostic
tests for naturally occurring emerging diseases such as SARS and West Nile
encephalitis, as well as for viral and bacterial agents that might be
employed by terrorists.
